Search

Displaying results 5201 - 5210 of 10000 in total
  1. Drug

    DR-01

    go.drugbank.com/drugs/DB18258
    Investigational

    DR-01 is a monoclonal antibody directed against human CD94.

  2. Drug

    MRT5005

    go.drugbank.com/drugs/DB18260
    Investigational

    MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).

  3. Drug

    Ferroheme

    go.drugbank.com/drugs/DB18267
    Investigational

    Synonyms: HEME BCategories: Cytochrome P-450 CYP3A Inhibitors, Heterocyclic Compounds, 1-Ring
  4. Drug

    MPB-1523

    go.drugbank.com/drugs/DB18334
    Investigational

    MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.[L48161]

  5. Drug

    HMI-204

    go.drugbank.com/drugs/DB18338
    Experimental

    HMI-204 is an adeno-associated virus serotype HSC15 expressing human arylsulfatase A

  6. Drug

    CN-105

    go.drugbank.com/drugs/DB18345
    Investigational

    CN-105 is a neuroprotective pentapeptide with the sequence Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2).

  7. Drug

    AMG-553

    go.drugbank.com/drugs/DB18346
    Investigational

    AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral

  8. Drug

    TCB-008

    go.drugbank.com/drugs/DB18352
    Investigational

    TCB-008 is an Allogeneic CD3+ T lymphocyte ex vivo expanded expressing the gamma delta T-cell receptor.

  9. Drug

    S-55746

    go.drugbank.com/drugs/DB18365
    Investigational

    Synonyms: (S)-N-(4-hydroxyphenyl)-3-(6-(3-(morpholinomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)benzo(d)(1,3)dioxol-5-yl)-n-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamideCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  10. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).